BioCentury

12:45 AM GMT, Feb 4, 2010
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Company News

FDA approves Oleptro

FDA approved an NDA from Labopharm Inc. (TSX:DDS; NASDAQ:DDSS) for Oleptro trazodone extended-release

Read the full 133 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.